Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for enzymatic synthesis of esomeprazole

A technology for esomeprazole and enzymatic synthesis, which is applied in directions such as fermentation, can solve problems such as complicated operation and many procedures, and achieve the effects of simplifying operation steps, reducing production costs and shortening time.

Active Publication Date: 2018-07-06
ZHEJIANG JINGXIN PHARMA +1
View PDF9 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The technical problem solved by the present invention is to overcome the defects that the existing esomeprazole enzymatic preparation process needs to use purified omeprazole sulfide as raw material, many procedures and complicated operation, and provides a one-pot method Method for enzymatically synthesizing esomeprazole

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for enzymatic synthesis of esomeprazole
  • Method for enzymatic synthesis of esomeprazole
  • Method for enzymatic synthesis of esomeprazole

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Embodiment 1: Construction of cyclohexanone monooxygenase genetically engineered bacteria

[0048] Commissioned Shanghai Jierui Bioengineering Co., Ltd. to custom synthesize cyclohexanone monooxygenase gene fragments SEQ ID NO.1, SEQ ID NO.3 and SEQ ID NO.5, and the corresponding encoded amino acid sequences are SEQ ID NO.2 and SEQ ID NO.2, respectively. ID NO.4 and SEQ ID NO.6. Then use the gene fragment as a template to amplify and expand by PCR (add Nde I and BamH I endonuclease fragments to both ends of the gene fragment), and insert the gene fragment into the pET28a plasmid using the Nde I and BamH I endonuclease sites At last, the vector obtained by ligation was transformed into Escherichia coli BL21 (DE3), and the recombinant Escherichia coli genetically engineered strains containing the cyclohexanone monooxygenase gene were constructed, respectively denoted as bacterial strain 1#, bacterial strain 2# and bacterial strain 3 #.

[0049] The primer sequences desi...

Embodiment 2

[0052] Embodiment 2: Construction of ketoreductase genetically engineered bacteria

[0053] Entrusted Shanghai Jierui Bioengineering Co., Ltd. to customize and synthesize the ketoreductase gene fragments SEQ ID NO.7, SEQ ID NO.9 and SEQ ID NO.11, and the corresponding encoded amino acid sequences are SEQ ID NO.8 and SEQ ID NO.10 respectively and SEQ ID NO.12. Then use the gene fragment as a template to amplify and expand by PCR (add Nde I and BamH I endonuclease fragments to both ends of the gene fragment), and insert the gene fragment into the pET28a plasmid using the Nde I and BamH I endonuclease sites , and finally the vector obtained by ligation was transformed into E. coli BL21(DE3), and recombinant E. coli genetically engineered strains containing the ketoreductase were constructed, which were respectively designated as strain 4#, strain 5# and strain 6#.

[0054] The primer sequences designed for strain 4# PCR amplification extension are as follows:

[0055] Forward p...

Embodiment 3

[0063] Embodiment 3: the construction of co-expression genetically engineered bacteria

[0064] With reference to "Molecular Cloning-A laboratory Manual" (third edition, 2001), the following enzyme digestion, connection, or preparation and transformation of competent cells were performed.

[0065] Design following primers F5 and R5, take the gene fragment of SEQ ID NO.1 cyclohexanone monooxygenase as template, expand the described cyclohexanone monooxygenase gene fragment by PCR amplification (add Nde I and BamH I endonuclease fragment); and utilize Nde I and BamH I endonuclease sites to insert the gene into the pET-21a plasmid, transfer the ligated vector into Escherichia coli Trans-T1, and construct the recombinant plasmid, named pETC. Colony PCR verification was performed with primer T7 / R3, the recombinant plasmid was extracted and sequenced, and the recombinant plasmid pETC with correct results was obtained.

[0066] Forward primer F5: GGCCATATGAATAATTTTGTTTAACTTTAAGAAGG...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for one-pot enzymatic synthesis of esomeprazole. The method comprises the following steps: reacting 2-mercapto-5-methoxybenzimidazole with 2-chloromethyl-3,5-dimethyl-4-methoxypyridine hydrochloride in a solvent in the presence of a base, and adjusting the pH of the obtained material to 6-9 after the reaction; and mixing the material, monooxygenase, auxiliary components and an aqueous solvent and reacting the obtained mixture with an oxidizing agent to produce esomeprazole. The method of the invention omits the step of refining and purifying of omeprazole thioether, is simplified in operation steps, shortened in synthesis time, high in catalytic reaction efficiency and greatly reduced in production cost, and has superior industrial application value.

Description

technical field [0001] The invention belongs to the technical field of pharmacy and bioengineering, in particular to a method for enzymatically synthesizing esomeprazole. Background technique [0002] Esomeprazole (esomeprazole) is the world's first isomer proton pump inhibitor (I-PPI) separated and synthesized by Sweden's AstraZeneca (AstraZeneca). It was first listed in the UK in September 2000. The S-isomer of prazole is currently the only specific inhibitor of the I-PPI proton pump. Its chemical name is S-5-methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)-1H- Benzimidazole has a chemical structure as shown in Formula I below. [0003] [0004] The bioenzymatic synthesis of esomeprazole has the advantages of high reaction yield, good chiral selectivity of the product, and no need for heavy metal chiral ligands. US5840552A screened a series of bacterial strains that can be used in biological oxidation reactions, the catalytic chiral selectivity is g...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12P17/16
CPCC12P17/165
Inventor 张敏张敏洁朱建荣黄悦
Owner ZHEJIANG JINGXIN PHARMA